PRESS RELEASE published on 05/09/2024 at 08:00, 2 years 3 months ago EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement Takeda announces enterprise-wide program to support growth and deliver core operating profit margin improvement, focusing on organizational agility and leveraging data, digital, and technology capabilities Takeda Pharmaceutical Company Limited Enterprise-wide Program Core Operating Profit Margin Organizational Agility Data Digital Technology
PRESS RELEASE published on 10/26/2023 at 08:00, 2 years 9 months ago EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS)
Published on 08/07/2026 at 23:15, 2 days 8 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 8 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 2 days 8 hours ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 2 days 9 hours ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/10/2026 at 07:00, 18 minutes ago Infracore SA announces partial exercise of the over-allotment option
Published on 08/10/2026 at 07:00, 18 minutes ago Infracore SA annonce l’exercice partiel de l’option de surallocation
Published on 08/10/2026 at 07:00, 18 minutes ago MindMaze Therapeutics Completes Organizational Simplification and Provides Update on Neuro.io Equity Financing
Published on 08/10/2026 at 07:00, 18 minutes ago ARYZTA protects profitability in a demanding environment; Capital returns to resume in 2027; Reviewing all options for Germany
Published on 08/10/2026 at 07:00, 18 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 18 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
Published on 08/07/2026 at 18:54, 2 days 12 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 2 days 12 hours ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 2 days 12 hours ago Disclosure of transactions in own shares from August 3 to August 7, 2026
